Bruker (BRKRP) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,433.00 |
| Dec 31, 2025 | -1,008.00 |
| Sep 30, 2025 | -1,011.00 |
| Jun 30, 2025 | -795.00 |
| Mar 31, 2025 | -824.00 |
| Dec 31, 2024 | -1,029.00 |
| Sep 30, 2024 | -1,088.00 |
| Jun 30, 2024 | -763.00 |
| Mar 31, 2024 | -528.00 |
| Dec 31, 2023 | -319.00 |
| Sep 30, 2023 | -278.00 |
| Jun 30, 2023 | -107.00 |
| Mar 31, 2023 | 86.00 |
| Dec 31, 2022 | 156.00 |
| Sep 30, 2022 | 298.00 |
| Jun 30, 2022 | 129.00 |
| Mar 31, 2022 | 166.00 |
| Dec 31, 2021 | 301.00 |
| Sep 30, 2021 | 416.00 |
| Jun 30, 2021 | 468.00 |
| Mar 31, 2021 | 151.00 |
| Dec 31, 2020 | -40.00 |
| Sep 30, 2020 | 102.00 |
| Jun 30, 2020 | 339.00 |
| Mar 31, 2020 | 529.00 |
| Dec 31, 2019 | 763.00 |
| Sep 30, 2019 | 791.00 |
| Jun 30, 2019 | 566.00 |
| Mar 31, 2019 | 543.00 |
| Dec 31, 2018 | 733.00 |
| Sep 30, 2018 | 922.00 |
| Jun 30, 2018 | 526.00 |
| Mar 31, 2018 | 530.00 |
| Dec 31, 2017 | 174.00 |
| Sep 30, 2017 | -154.00 |
| Jun 30, 2017 | -30.00 |
| Mar 31, 2017 | -291.00 |
| Dec 31, 2016 | -279.00 |
| Sep 30, 2016 | -588.00 |
| Jun 30, 2016 | -760.00 |
| Mar 31, 2016 | -781.00 |